Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 07, 2018 07:00 ET | Source: Kamada Ltd.

Kamada Reports Financial Results for Second Quarter and First Six Months of 2018

Total Revenues for Second Quarter were $33.8 Million, a 4% Increase Over Second Quarter of 2017Total Revenues for First Half of 2018 were $51.3 Million, a 16% Increase Over First Half of 2017Gross...
August 01, 2018 07:00 ET | Source: Kamada Ltd.

Kamada to Announce Second Quarter and Six Months Ended June 30, 2018 Financial Results and Host Conference Call on August 7

REHOVOT, Israel, Aug. 01, 2018 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ & TASE: KMDA), a plasma-derived protein therapeutics company, today announced that it will release financial results for...
July 10, 2018 07:00 ET | Source: Kamada Ltd.

Kamada Receives Positive Scientific Advice from European Medicines Agency on a New Phase 3 Study Design for Inhaled AAT

REHOVOT, Israel, July 10, 2018 (GLOBE NEWSWIRE) -- Kamada Ltd. (the "Company") (NASDAQ:KMDA) (TASE:KMDA), a plasma-derived protein therapeutics company, today announced that it has received positive...
June 04, 2018 07:00 ET | Source: Kamada Ltd.

Results of Kamada’s Phase 2 Trial of Alpha-1 Antitrypsin in Newly Diagnosed Type-1 Diabetes Patients to be Presented at the Upcoming American Diabetes Association’s 78th Scientific Sessions

REHOVOT, Israel, June 04, 2018 (GLOBE NEWSWIRE) -- Kamada Ltd. (Nasdaq:KMDA) (TASE:KMDA), a plasma-derived protein therapeutics company, today announced that the results from the Company’s Phase 2...
May 15, 2018 07:00 ET | Source: Kamada Ltd.

Kamada Reports Financial Results for First Quarter of 2018

Reaffirming Guidance of $116 to $120 Million in Total Revenues for 2018U.S. Launch of KEDRAB® [Human Rabies Immune Globulin (HRIG)] Represents Significant Company Milestone REHOVOT, Israel, May 15,...
May 09, 2018 07:00 ET | Source: Kamada Ltd.

Kamada to Announce First Quarter 2018 Financial Results and Host Conference Call on May 15

REHOVOT, Israel, May 09, 2018 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ:KMDA) (TASE:KMDA), a plasma-derived protein therapeutics company, today announced that it will release financial results for the...
May 08, 2018 07:00 ET | Source: Kamada Ltd.

Kedrion Biopharma and Kamada Announce KEDRAB® (Rabies Immune Globulin [Human]) Now Shipping; Distribution Timed to Meet Spring/Summer Demand for Product

FORT LEE, N.J. and REHOVOT, Israel, May 08, 2018 (GLOBE NEWSWIRE) -- Kedrion Biopharma and Kamada Ltd. (NASDAQ:KMDA) (TASE:KMDA), two leading human-derived protein therapeutics companies, announced...
April 23, 2018 07:00 ET | Source: Kamada Ltd.

Kamada Received Feedback from FDA on Proposed Phase 3 Protocol for Inhaled Alpha-1-Antitrypsin for Treatment of Alpha-1 Antitrypsin Deficiency Disease

REHOVOT, Israel, April 23, 2018 (GLOBE NEWSWIRE) -- Kamada Ltd. (the "Company") (Nasdaq:KMDA) (TASE:KMDA), a plasma-derived protein therapeutics company, today announced that the Company recently...
February 07, 2018 07:00 ET | Source: Kamada Ltd.

Kamada Reports Financial Results for Fourth Quarter and Full-Year 2017

Total Revenues for Fiscal 2017 were $102.8 Million, up 33% Over Fiscal 2016; Exceeded Full-Year Revenue Guidance of $100 MillionFull-Year Proprietary Products Revenues up 42% Year-Over-Year Gross...
February 02, 2018 08:00 ET | Source: Kamada Ltd.

Kamada to Announce Fiscal Year 2017 Financial Results and Host Conference Call on February 7

REHOVOT, Israel, Feb. 02, 2018 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ:KMDA) (TASE:KMDA), a plasma-derived protein therapeutics company focused on orphan indications, today announced that it will...